Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Ocugen, Inc. | ocgn-20191231x10kxex321.htm |
| EX-31.2 - EX-31.2 - Ocugen, Inc. | ocgn-20191231x10kxex312.htm |
| EX-31.1 - EX-31.1 - Ocugen, Inc. | ocgn-20191231x10kxex311.htm |
| EX-21.1 - EX-21.1 - Ocugen, Inc. | ocgn-20191231x10kxex211.htm |
| EX-10.30 - EX-10.30 - Ocugen, Inc. | ocgn-20191231x10kxex101.htm |
| EX-10.29 - EX-10.29 - Ocugen, Inc. | ocgn-20191231x10kxex10.htm |
| EX-4.1 - EX-4.1 - Ocugen, Inc. | ocgn-20191231x10kxex41.htm |
| 10-K - 10-K - Ocugen, Inc. | ocgn-20191231.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-3 No. 333-234127) of Ocugen, Inc. and in the related Prospectus of our report dated March 27, 2020, with respect to the consolidated financial statements of Ocugen, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Philadelphia, Pennsylvania
March 27, 2020